Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-Month clinical outcomes

Journal of Cardiovascular Medicine

Volumn 10, Issue 6, 2009, Pages 469-473

  Sardella, Gennaro ^a   Colantonio, Riccardo ^a   De Luca, Leonardo ^a   Conti, Giulia ^a   Di Roma, Angelo ^a   Mancone, Massimo ^a   Canali, Emanuele ^a   Benedetti, Giulia ^a   Fedele, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Percutaneous coronary angioplasty

Indexed keywords

'TAXUS'; CLOPIDOGREL; CYPHER; HEPARIN; JANUS CARBOSTENT; PACLITAXEL; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL FEATURE; CORONARY STENT; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; STENT THROMBOSIS; SURVIVAL RATE; TREATMENT OUTCOME; AGED; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; DRUG COMBINATION; INSTRUMENTATION; ITALY; MIDDLE AGED; MORTALITY; RADIOGRAPHY; REGISTER; RISK ASSESSMENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649172619     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283297c23     Document Type: Article

References (28)

1. Moses JW, Leon MB, Popma JJ, Popma JJ, Fitzgerald PJ, Holmes DR, et al., SIRIUS Investigators. Sirolimus-eluting stent with a standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
2. Schofer J, Schluter M, Gersglick AH, Gershlick AH, Wijns W, Garcia E, et al., E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with atherosclerotic lesions in small coronary arteries: double-bind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362:1093-1099.
3. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al., C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43:1110-1115. (Pubitemid 38352997)
4. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I: six and twelve-month results from a randomized, double-bind trial on a slow-release paclitaxel-eluting stent for the novo coronary artery lesions. Circulation 2003; 107:38-42. (Pubitemid 36070930)
5. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al., TAXUS-IV Investigators. A polymer-based paclitaxel-eluting stent in patient with coronary artery disease. N Engl J Med 2004; 350:221-231. (Pubitemid 38067635)
6. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al., TAXUS V Investigators. Comparison of polymer-based paclitaxel-eluting stent with a bare-metal stent in patients with complex coronary artery disease: a randomized controlled trail. JAMA 2005; 294:1215-1223.
7. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al., TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxeleluting stents for coronary artery lesions. Circulation 2003; 108:788-794.
8. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39:183-193.
9. Schofer J, Schluter M. Coronary restenosis after implantation of drugeluting stents. Minerva Cardioangiol 2005; 53:43-48. (Pubitemid 41556807)
10. Radke PW, Kaiser A, Frost G, Sigwart U. Outcomes after treatment of coronary in-stent restenosis; results from a systematic review using metaanalysis techniques. Eur Heart J 2003; 24:266-274. (Pubitemid 36207082)
11. Bossi I, Klersy C, Black AJ, Cortina R, Choussat R, Cassagneau B, et al. In-stent restenosis: long term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 2000; 35:1569-1576. (Pubitemid 30307502)
12. Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reimers B, et al., RESCUT Investigators. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT). J Am Coll Cardiol 2004; 43:943-999. (Pubitemid 38352970)
13. Dauerman HL, Baim DS, Cutlip DE, Sparano AM, Gibson CM, Kuntz RE, et al. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. Am J Cardiol 1998; 82:277-284. (Pubitemid 28364240)
14. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, Lopez-Minguez JR, et al., Restenosis Intra-stent: Balloon Angioplasty Versus Elective Stenting (RIBS) Investigators. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003; 42:796-805.
15. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359:551-557. (Pubitemid 34178435)
16. Mishkel GJ, Moore AL, Markwell S, Shelton MC, Shelton ME. Long-term outcomes after management restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007; 49:181-184. (Pubitemid 46054395)
17. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100:1872-1878. (Pubitemid 29511140)
18. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, et al., Stents And Radiation Therapy (START) Investigators. Randomized trial of 90Sr/90Y beta-radiation to inhibit the recurrence of restenosis after stenting. Circulation 2002; 106:1090-1096.
19. Leon MB, Teirstein PS, Moses JW. Declining long-term efficacy of vascular brachytherapy for in-stent restenosis: five year follow-up from the gamma 1 randomised trial [abstract]. Circulation 2004; 110:405.
20. Baierl V, Baumgartner S, Pollinger B, Leibig M, Rieber J, Konig A, et al. Three year clinical follow-up after Strontium-90/Yttrium-90 beta-irradiation for the treatment of in-stent coronary restenosis. Am J Cardiol 2005; 96:1399-1403. (Pubitemid 41566621)
21. Alfonso F, Auge JM, Zueco J, Bethencourt A, Lopez-Minguez JR, Hernandez JM, et al., RIBS Investigators. Long-term results (three to five years) of the restenosis intrastent: balloon angioplasty vesus elective stenting (RIBS) randomized study. J Am Coll Cardiol 2005; 46:756-760. (Pubitemid 41224795)
22. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, Fernandez C, Escaned J, Bañuelos C, et al., Restenosis intra-stent: balloon angioplasty versus elective stent implantation (RIBS-I) and restenosis intra-stent: balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II) investigators. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv 2008; 72:459-467.
23. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005; 111:2107-2111. (Pubitemid 40577906)
24. Kastrati A, Mehilli J, von Beckerath N, von Beckerath N, Dibra A, Hausleiter J, et al., ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrence in patient with coronary in-stent restenosis: a randomized controlled trial (ISAR-DESIRE). JAMA 2005; 293:165-171.
25. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, et al., SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006; 295:1264-1273.
26. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, et al., TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006; 295:1253-1263.
27. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Perez-Vizcayno MJ, Mehilli J, Schomig A. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis. Meta-analysis of randomized trials. J Am Coll Cardiol 2007; 49:616-623. (Pubitemid 46177448)
28. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, Lopez- Minguez JR, et al., RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent Balloon Angioplasty versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006; 47:2152-2160. (Pubitemid 43795079)